GlassScriptPhysician profile
Elio Donna
NPI 1518993732
$4,248.44
in general payments reported to CMS, 2019-2025
8 companies · $2,643 in 2025
The $2,643 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.22 · 2020: $14.99 · 2021: $1,149 · 2023: $17.58 · 2024: $353 · 2025: $2,643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,350 · Food and Beverage: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,350.00 |
| Food and Beverage | $663.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,350.00 | 2025 | Rybrevant |
| Intuitive Surgical, INC. | $1,275.19 | 2021-2024 | |
| Caris Mpi, INC. | $138.12 | 2025 | Mi Cancer Seek |
| Regeneron Healthcare Solutions, INC. | $120.71 | 2024 | Libtayo |
| Merck Sharp & Dohme LLC | $113.63 | 2025 | Keytruda |
| Erbe USA INC | $91.22 | 2019-2025 | Erbecryo |
| Boston Scientific Corporation | $80.12 | 2020-2024 | Coredx, Exalt Model D |
| Ambu INC. | $79.45 | 2024-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elio Donna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.